Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06570395 · ClinicalTrials.gov registry record
Osteopathic Manipulative Treatment in the Third Trimester of Pregnancy
A clinical trial, sponsored by Corewell Health South.
- Terminated
- Registry status
- 5
- Enrollment target
NCT06570395: Clinical Trial study, sponsored by Corewell Health South.
NCT06570395 is a clinical trial that was terminated before completion, run by Corewell Health South. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06570395 was terminated before completion, sponsored by Corewell Health South.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Osteopathic Manipulative Therapy (OMT) is a hands-on approach to treating conditions that affect all areas of the body. Physicians trained in OMT (Doctors of Osteopathic Medicine or DO) use OMT to correct structural imbalances in the body, relieve pain, and improve circulation. Research shows that manual therapy is equally or more effective in treating pain and improving function versus oral analgesics (Bodine). OMT can decrease cost and improve function in patients with a minimal adverse effect profile. OMT applications include relieving asthma, irritable bowel syndrome, fibromyalgia, migraines, carpal tunnel syndrome, and sports-related injuries. In addition to the indications listed above, there is a growing body of research surrounding the use of OMT in pregnancy and its use in treatment and prevention of complications peripartum. Research Question: Does OMT during the third trimester of pregnancy improve delivery outcomes including: decreased labor times, less utilization of analgesics, fewer incidences of meconium fluid and perineal lacerations, and reduced risk of conversion to c-section or operative vaginal delivery? Though all research has shown that OMT is safe in pregnancy, there has been conflicting data on its benefits during the peripartum period. Additional research is needed to show its utility in decreasing labor times and need for analgesics during labor and reducing incidence of adverse outcomes including perineal lacerations and conversion to c-section and operative vaginal delivery. The current study will add to the growing body of knowledge about OMT during pregnancy and its potential benefits outside of musculoskeletal pain relief.
Primary Outcome
Does OMT in the 3rd trimester of pregnancy shorten duration of labor? The investigators will compare a control group to a group who received OMT.
Interventions
- PROCEDURE Osteopathic Manipulative Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2024-07-16 |
| Est. Completion | 2025-12-29 |
Why NCT06570395 stopped before completion
NCT06570395 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Osteopathic Manipulative Treatment is the first listed.
NCT06570395 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06570395 about?
NCT06570395 is a clinical study titled "Osteopathic Manipulative Treatment in the Third Trimester of Pregnancy". Osteopathic Manipulative Therapy (OMT) is a hands-on approach to treating conditions that affect all areas of the body. Physicians trained in OMT (Doctors of Osteopathic Medicine or DO) use OMT to correct structural imbalances in the body, relieve pain, and improve circulation. Research shows that m...
What is the current status of trial NCT06570395?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2024-07-16. Estimated completion is 2025-12-29.
What interventions are being tested in trial NCT06570395?
The interventions under investigation include: Osteopathic Manipulative Treatment (PROCEDURE).
Who is sponsoring clinical trial NCT06570395?
This trial is sponsored by Corewell Health South, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI